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ABSTRACT  26 
Pharmaceuticals are biologically active molecules that may exert toxic effects to a wide 27 
range of aquatic organisms. They are considered contaminants of emerging concern due 28 
to their common presence in wastewaters and in the receiving surface waters, and the 29 
lack of specific regulations to monitor their environmental occurrence and risks. In this 30 
work, the environmental exposure and risks of pharmaceuticals have been studied in the 31 
Mijares River, Eastern Mediterranean coast (Spain). A total of 57 surface water samples 32 
from 19 sampling points were collected in three monitoring campaigns between June 33 
2018 and February 2019. A list of 40 compounds was investigated using a quantitative 34 
target UHPLC-MS/MS method. In order to complement the data obtained, a wide-scope 35 
screening of pharmaceuticals and metabolites was also performed by UHPLC-HRMS. The 36 
ecological risks posed by the pharmaceutical mixtures were evaluated using species 37 
sensitivity distributions built with chronic toxicity data for aquatic organisms. In this 38 
study, up to 69 pharmaceuticals and 9 metabolites were identified, out of which 35 39 
compounds were assessed using the quantitative method. The highest concentrations in 40 
water corresponded to acetaminophen, gabapentin, venlafaxine, valsartan, ciprofloxacin 41 
and diclofenac. The compounds that were found to exert the highest toxic pressure on 42 
the aquatic ecosystems were principally analgesic/anti-inflammatory drugs and 43 
antibiotics. These were: phenazone > azithromycin > diclofenac, and to a lower extent 44 
norfloxacin > ciprofloxacin > clarithromycin. The monitored pharmaceutical mixtures are 45 
expected to exert severe ecological risks in areas downstream of WWTP discharges, with 46 
the percentage of aquatic species affected ranging between 65% and 82% in 3 out of the 47 
19 evaluated sites. In addition, five antibiotics were found to exceed antibiotic resistance 48 
thresholds, thus potentially contributing to resistance gene enrichment in environmental 49 
bacteria. This work illustrates the wide use and impact of pharmaceuticals in the area 50 
under study, and the vulnerability of surface waters if only conventional wastewater 51 
treatments are applied. Several compounds included in this study should be incorporated 52 
in future water monitoring programs to help in the development of future regulations, 53 
due to their potential risk to the aquatic environment. 54 
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1. INTRODUCTION 63 
The prevention of water bodies deterioration is an urgent issue nowadays. Among other 64 
matters, it is necessary to accurately monitor the presence of a wide variety of organic 65 
contaminants in order to preserve the ecological status of aquatic ecosystems. In this 66 
context, pharmaceuticals are of current concern due to their widespread use and 67 
frequent detection in the water cycle. Pharmaceuticals can reach water bodies from 68 
different sources, such as a human consumption (Botero-Coy et al., 2018; García-Galán 69 
et al., 2016), landfill leachates (Lu et al., 2016; Masoner et al., 2014), use of wastewater 70 
treatment plants (WWTPs) sludge as fertilizers (Behera et al., 2011), effluents from 71 
hospitals (Della-Flora et al., 2019; Verlicchi et al., 2012) or improper disposal of unused 72 
or expired medicines (Bashaar et al., 2017; Tong et al., 2011). Due to the poor removal 73 
efficiency of most conventional WWTPs (Al-Odaini et al., 2010; Behera et al., 2011), it is 74 
not surprising that pharmaceuticals are found in treated effluents and reach receiving 75 
surface waters (Botero-Coy et al., 2018; Collado et al., 2014; Gao et al., 2012; Gracia-Lor 76 
et al., 2012; Hernández et al., 2019a; Ibáñez et al., 2017; Paíga et al., 2017; Picó et al., 77 
2020; Rico et al. 2016) and even drinking water sources (Boleda et al., 2014; Bruce et al., 78 
2010; Praveena et al., 2019).  79 
Pharmaceuticals are biologically active molecules designed to target a varied range of 80 
human receptors and that display different toxicological modes of action, depending on 81 
the biological endpoint that is evaluated. A recent review on the environmental exposure 82 
and toxicity data for 22 pharmaceuticals shows that hormones, antiepileptics, anti-83 
inflammatories and antibiotics are generally the TCs posing the highest ecotoxicological 84 
risks (Pereira et al., 2020). However, consumption patterns and removal efficiencies vary 85 
across different river basins, which result in diverse complex mixtures, that need to be 86 
evaluated case-by-case (Altenburger et al., 2015).  87 
A significant amount of research has been carried out on the occurrence of 88 
pharmaceuticals in surface waters, but only data from parent compounds are normally 89 
reported (Boix et al., 2015; Ferrer et al., 2010; Grabic et al., 2012; Gracia-Lor et al., 2011; 90 
Huntscha et al., 2012; Ibáñez et al., 2009). However, there are more and more data 91 
available evidencing that the unaltered compounds are just the “top of the iceberg”, 92 




excreted in urine (Hernández et al., 2019a). In the last few years, several papers have 94 
reported the occurrence of many metabolites in surface and wastewaters (Boix et al., 95 
2016; Della-Flora et al., 2019; Gracia-Lor et al., 2014; Ibáñez et al., 2017; Langford and 96 
Thomas, 2011; Rúa-Gómez and Püttmann, 2012). Apart from analytical drawbacks, such 97 
as the lack of reference standards and the absence of priority compounds lists, the 98 
evaluation of the toxicity of metabolites and transformation products (TPs) involves 99 
considerable effort (Lindholm-Lehto et al., 2016). However, it is of importance as they 100 
can be as persistent and/or toxic as the parent compound and can have negative effects 101 
on different aquatic organisms (Rivera-Jaimes et al., 2018). For this reason, they should 102 
be gradually included in analytical methods and in aquatic risk assessments (Hernández 103 
et al., 2019a; Santana-Viera et al., 2016).  104 
Until recently, environmental regulations barely included maximum allowable 105 
concentration levels for pharmaceuticals in surface waters. The European Commission 106 
(European Commission, 2018) establishes a Watch List of substances that must be 107 
followed up as part of public policies. The objective of that list is to collect data from the 108 
Member States about the concentration levels of the included pharmaceuticals in the 109 
water bodies and to decide, in a later stage, whether they can be considered as priority 110 
substances in the regular monitoring of water quality. Five antibiotics (i.e. the 111 
fluoroquinolone ciprofloxacin, the penicillin amoxicillin and the macrolides azithromycin, 112 
clarithromycin, erythromycin) have already been included in the current Watch List. 113 
Recent studies indicate that the aquatic risk of pharmaceuticals, such as carbamazepine 114 
and ciprofloxacin, has increased from 10 to 20 times in the last 20 years due to the 115 
demographic concentration in urban areas and the low dilution capacity of surface waters 116 
in (semi-)arid areas (Oldenkamp et al., 2019). The presence of antibiotics in the 117 
environment is of special concern, as it can lead to the development of bacterial 118 
resistance genes, a fact that has already been observed even in pristine areas such as the 119 
Antarctic (Hernández et al., 2019b) and which may represent a serious problem in fighting 120 
some diseases (Mokh et al., 2017). Recent investigations show that urban WWTPs 121 
constitute hotspots for antibiotic emissions, contributing to the enrichment of resistance 122 
genes in surface water ecosystems (Buelow et al., 2020). In this regard, threshold 123 




antibiotics to aid the assessment of their respective resistance development risks 125 
(Bengtsson-Palme and Larsson, 2016; Rico et al., 2017), and to prioritize compounds and 126 
management practices that should be implemented at a watershed scale.  127 
One of the main reasons for the increase of data on the presence of pharmaceuticals in 128 
water is the relevant role of modern environmental analytical chemistry (Hernández et 129 
al., 2019a). Most data reported nowadays are based on target quantitative methods 130 
commonly using ultra high-performance liquid chromatography coupled to tandem mass 131 
spectrometry (UHPLC-MS/MS), which offers excellent sensitivity, selectivity and 132 
robustness (Beccaria and Cabooter, 2020; Campos-Mañas et al., 2017; García-Galán et 133 
al., 2016; van Nuijs et al., 2010). However, the application of target methodologies may 134 
provide incomplete results as other compounds present in the sample could remain 135 
ignored in the analysis. Then, a screening based on high resolution MS (HRMS) becomes 136 
necessary in order to identify as many contaminants as possible, even when reference 137 
standards are not available at the laboratory (Aceña et al., 2015; Boix et al., 2016; 138 
Hernández et al., 2015a, 2015b). 139 
The aim of this study was to assess the occurrence and ecological risks of a wide variety 140 
of pharmaceuticals and metabolites in the Mijares River, located in Eastern 141 
Mediterranean Spain. A total of 57 surface water samples were collected in three 142 
different campaigns over one year. Samples were quantitatively analyzed by UHPLC-143 
MS/MS for the determination of 40 target pharmaceuticals. Additionally, a screening by 144 
UHPLC-HRMS was performed in order to complement the quantitative results obtained. 145 
The results of the quantitative analysis were used to perform a probabilistic risk 146 
assessment for aquatic organisms, which helped to highlight individual compounds and 147 
pharmaceutical mixtures that are posing an ecotoxicological risk. Moreover, the 148 
monitored antibiotics were evaluated in regards to their resistance development risks. 149 
Overall, this study contributes to the identification of pharmaceutical compounds that 150 
need to be further monitored and that are candidates to be included in future updates of 151 




2. EXPERIMENTAL 153 
2.1 Chemicals and materials  154 
See Supplementary Material (S.M.) 155 
2.2 Description of the sampling sites and sample collection  156 
The Mijares River originates in Aragón (at 1.600 m in Sierra de Gúdar, in the municipality 157 
El Castellar, province of Teruel) and ends in the Mediterranean Sea, Castellón, Eastern 158 
Spain (see Figure 1). It is 156 km long with a 5.466 km2 wide basin, which represents 13% 159 
of the total demarcation of the Jucar Hydrographic Confederation. The river is an 160 
important source of irrigation water in the lower basin, which is an important agricultural 161 
area with predominance of citrus crops (Garófano-Gómez et al., 2013). 162 
Water samples were taken at 19 different points (see Figure 1), covering almost all the 163 
Mijares River, from its source until its estuary: points 1-6 are sited in the upper section of 164 
the river, 7-14 in the middle section, 15-18 in the lower section, and point 19 in the river 165 
mouth. All sampling sites were selected based on different characteristics and/or 166 
accessibility (Table S1). In the municipality of Sarrión (Teruel), three sampling points were 167 
considered due to their proximity to a fertilizer factory (point 2) or to a fish farm (points 168 
3 and 4). The potential contribution of small towns in terms of emerging contaminants 169 
might be attributed to four WWTPs discharging their effluents into the river. For this 170 
reason, several sampling sites were selected downstream of the WWTPs: points 9 and 10, 171 
near Montanejos (WWTP flow 627 m3/day; population served 1.513 p.e); 11 near Toga 172 
(WWTP flow 21 m3/day; population served 66 p.e); 17 near Vila-real (WWTP flow 3.666 173 
m3/day; population served 16.449 p.e); and 18 near Almassora (WWTP flow 7.386 174 
m3/day; population served 34.337 p.e) (Table S2) (EPSAR, 2020). Also, two sampling sites 175 
(13 and 14), located downstream of a solid waste treatment plant (SWTP) near Onda 176 
(Castellón), were included in this study. Waters from three reservoirs located in the 177 
Mijares River were also sampled: 5 (Toranes reservoir, Teruel), 7 and 8 (Arenós reservoir, 178 
Castellón) and 12 (Sitjar reservoir, Castellón). 179 
Three sampling campaigns were conducted in order to monitor pharmaceuticals 180 
concentrations along different periods: June 2018 (1st campaign, summer), September 181 




campaign, 19 surface water samples, one from each sampling point, were collected in 183 
polyethylene bottles, transported to the laboratory on the same day (within max. 6h) in 184 
refrigerated isothermal containers, and stored at -20 °C until analysis. 185 
2.3 Sample treatment 186 
2.3.1. Quantitative analysis 187 
The procedure applied for quantitative UHPLC-MS/MS analysis was based on 188 
methodology previously developed by our research group (Boix et al., 2015; Botero-Coy 189 
et al., 2018) using direct injection of the sample, without any pre-concentration. Briefly, 190 
2 mL of water was centrifuged at 12.000 rpm for 10 min. Subsequently, 50 µL of 191 
isotopically labelled internal standard (ILIS) mix solution of 1 µg/L was added to 950 µL of 192 
the centrifuged water sample (final ILIS concentration in the sample injected, 50 ng/L) . 193 
Finally, 50 L was injected into the UHPLC-MS/MS system.  194 
2.3.2. Screening analysis 195 
The UHPLC-HRMS screening required a previous generic sample extraction and pre-196 
concentration. This was performed by solid-phase extraction (SPE), following the 197 
procedure described by Pitarch et al. (2016). Figure S1 shows a flowchart of the extraction 198 
procedure. Briefly, 100 mL of water was passed through an Oasis® HLB (150 mg) cartridge. 199 
After elution, the extract was reconstituted with 100 L of methanol:water (10:90, v/v) 200 
and 20 L were injected into the UHPLC-QTOF MS. 201 
2.4 Instrumentation 202 
Quantitative analyses was performed using a Waters ACQUITY UPLC® (Waters Corp.) 203 
equipped with a binary pump system was interfaced to a Xevo TQ-STM triple quadrupole 204 
(QqQ) mass spectrometer (Waters Corp.). For qualitative screening  a Waters ACQUITY 205 
UPLC® (Waters Corp.) interfaced to a hybrid quadrupole-orthogonal acceleration-TOF 206 
mass spectrometer (XEVO G2 QTOF, Waters) was used. For more details related to the 207 
instrumentation used see S.M. 208 
2.5 Quantitative LC-MS/MS analysis and quality assurance 209 
In total, 40 pharmaceuticals (Table 1) from different therapeutical classes were selected 210 




shown in Table S3. At least, seven-point calibration curves (0.005-20 g/L) were injected 212 
at the beginning and the end of each sequence. As the samples were analysed by direct 213 
injection, without any pre-concentration step, the lowest calibration level (LCL) was taken 214 
as the limit of quantification in samples (Table S3). A compound was considered as 215 
“detected” when its concentration was below LCL and at least one q/Q ratio was 216 
accomplished allowing in this way its reliable identification. For the constructions of 217 
graphs, risk assessment evaluation, and for discussion of results obtained, the cut-off 218 
value used for detected positives was half of their LCL. 219 
Quality control (QC) samples, consisting on three surface waters each fortified at three 220 
concentration levels (0.01, 0.1 and 1 g/L), were analysed together with the samples (see 221 
Table S4). QCs recoveries between 60 and 140% were considered satisfactory (SANTE, 222 
2019). For many compounds, the corresponding ILIS was used for matrix effects 223 
correction, ensuring an accurate quantification (Table S3). The ratio between the 224 
qualitative and quantitative transitions (q/Q ratio) as well retention time deviation (± 0.1 225 
min) were used for the reliable identification of positive findings (SANTE, 2019).  226 
2.6. UHPLC-HRMS screening 227 
A great number of organic micro-pollutants were investigated by screening based on 228 
UHPLC-QTOF MS. Accurate-mass data generated at low and high collision energy were 229 
processed by ChromaLynxTM Application Manager (within MassLynx) in combination with 230 
a home-made database, containing a large number of pharmaceuticals and their main 231 
metabolites. In total, the presence of more than 900 compounds was investigated (see 232 
Table S5 in S.M.). This software applies a “post-target” processing method by monitoring 233 
exact masses of the suspect analytes and obtains the corresponding narrow-window 234 
Extracted Ion Chromatogram (nw-EICs). 235 
The database included, at least, the name and elemental composition of the parent 236 
compounds (occasionally adducts). Information on retention time (Rt), main fragment 237 
ions and adducts was also added when reference standards were available, which greatly 238 
helped to facilitate and support the identification process.  239 
When a chromatographic peak was observed at the corresponding exact mass but the 240 




bromine atoms were present) as well as fragment ions were evaluated and their 242 
compatibility with the chemical structure of the suspect compound was assessed. 243 
Tentative identification was reinforced by agreement with MS/MS product ions reported 244 
in literature or available databases (preferably in exact mass). For more information see 245 
(Hernández et al., 2015a, 2015b). 246 
2.7. Ecological risk assessment 247 
The probability that exposure concentrations result in unacceptable effects for aquatic 248 
organisms was calculated based on the Species Sensitivity Distributions (SSD) approach 249 
(Posthuma et al. 2002). The Potentially Affected Fraction (PAF) was calculated for 250 
individual compounds, and the multi-substance Potentially Affection Fraction (msPAF), 251 
for contaminant mixtures, following the methods described by de Zwart and Posthuma 252 
(2005). Risks were calculated using the SSDs provided by Posthuma et al. (2019) for 253 
chronic exposure. In their study, the SSD parameters µ (median of the log-transformed 254 
toxicity values) and σ (standard deviation of log-transformed toxicity values or slope) 255 
were calculated using a log-normal distribution on the basis of chronic toxicity data 256 
(primarily No Observed Effect Concentrations, NOECs) for bacteria, algae, invertebrates 257 
and fish. Since for some compounds chronic toxicity data is very limited, acute-to-chronic 258 
extrapolation techniques and read-across (i.e., Quantitative-Structure Activity 259 
Relationships, QSARs) was often applied for their derivation. The robustness of the SSD 260 
parameters was evaluated on the basis of the methods described by Posthuma et al. 261 
(2019), which consider four quality aspects: (1) the availability of a sufficient number of 262 
data to calculate the SSD µ and σ, (2) the biodiversity coverage, (3) the origin of the 263 
toxicity data (i.e., experimental, extrapolated or read-across), and (4) the type of 264 
extrapolation (in case the data was extrapolated). The SSD parameters of the compounds 265 
that were detected at least once in this study are provided in Table S6 together with their 266 
quality scores, while a detailed description of the quality scores is provided in Table S7. 267 
When there was no chronic toxicity data for a specific compound, the µ was derived by 268 
subtracting 1 to the µ of the SSD built with acute toxicity data (i.e., assuming an acute-to-269 
chronic extrapolation factor of 10 for the species assemblage), and using a σ of 0.7. A σ 270 




too low according to the criteria established by Posthuma et al. (2019). The σ value of 0.7 272 
is the average SSD slope for the 12386 chemicals evaluated by Posthuma et al. (2019). 273 
The monitored pharmaceuticals were classified into eleven Therapeutic Classes (TCs). 274 
Then, the toxic pressure of the compounds within each of the TCs and their mixtures was 275 
calculated for each sample. First, the Hazard Unit (HU) was calculated for each compound 276 
in each sampling site by dividing the logarithm of the measured concentration by the SSD 277 
µ. These HUs are used to adjust for differences in the potency of the evaluated 278 
compounds. Next, the concentration addition model was used to calculate the msPAF 279 
corresponding to each TC (msPAFTC) in each sample using the Microsoft Excel © function 280 
(Eq. 1).  281 
msPAFTC  = 𝑁𝑂𝑅𝑀. 𝐷𝐼𝑆𝑇 (𝐻𝑈𝑇𝐶 , 0, 𝜎𝑇𝐶 , 1)                                             Eq. 1 282 
Where HUTC is the sum of the HUs for each compound in the TC, and σ TC is the average σ 283 
for all compounds in the TC.  284 
After obtaining the msPAFTC for each TC, the total toxicity of the sample (msPAFTotal) was 285 
calculated using the response addition model (Eq. 2). 286 
msPAFTotal  = 1 − ∏ (1 −  msPAFTC,i)
𝑛
𝑖=1                                                                          Eq. 2 287 
Finally, the msPAFTotal for each sample was represented with the relative contribution of 288 
each TC to the total toxic pressure. In our study, the PAF and the msPAFTotal represent the 289 
fraction of species of the aquatic ecosystem that will be affected (i.e., the NOEC is 290 
exceeded) by the chronic exposure to an individual compound or the pharmaceutical 291 
mixture, respectively. In this study, PAF and msPAFTotal values between 5% and 25% were 292 
considered to result in moderate ecological risks, while values above 25% were 293 
considered to induce severe risks (see section 3.4 for rationale).  294 
2.8 Antibiotic resistance risks 295 
The risks of promoting antibiotic resistance in environmental bacteria were calculated 296 
using the resistance Predicted No Effect Concentrations (PNECs) proposed by Bengtsson-297 
Palme and Larsson (2016) for all the evaluated antibiotics except furaltadone, oxolinic 298 
acid and sulfadiazine, for which resistance PNECs are not available. Risk Quotients (RQs) 299 




PNECs, so that a RQ quotient larger than one indicates a potential risk of antibiotic 301 
resistance development. 302 
3. RESULTS AND DISCUSSION 303 
3.1 Quantitative analysis by UHPLC-MS/MS (QqQ) 304 
3.1.1 Quality control samples 305 
Especial emphasis was made on QCs evaluation in order to support the reliability of 306 
quantitative data reported. Table S4 shows the average results obtained for 9 QCs 307 
analysed (one QC per spiking level and per sampling campaign, this is, 3 replicates per 308 
each spiking level). It should be noted that QCs at lowest fortification level were only 309 
performed in the first campaign (n=3). Recoveries were generally between 60 and 140% 310 
(SANTE, 2019), and mostly in the 80-120% range. The use of analyte-ILIS and the absence 311 
of complex sample treatment process surely facilitated obtaining satisfactory quality 312 
controls, with a few exceptions. The most relevant were for the antibiotics ciprofloxacin 313 
and norfloxacin, whose recovery values were slightly above 200% and poorly 314 
reproducible. The lack of sensitivity of our instrumentation in negative mode prevented 315 
the determination of the drugs measured under this mode (bezafibrate, gemfibrozil, 316 
ketoprofen and naproxen) at the low fortification levels tested and only QC recoveries at 317 
1 g/L could be calculated for these compounds. The antibiotics clarithromycin and 318 
roxithromycin showed unsatisfactory recoveries in some cases, especially at the highest 319 
level of fortification, probably because their analyte-ILIS was not available and therefore 320 
matrix effects could not be  corrected. Regarding data reported in this paper for water 321 
samples, the unsatisfactory QCs recoveries only affected to ciprofloxacin and norfloxacin, 322 
and therefore those values must be taken as semi-quantitative. The reason might be the 323 
low ILIS concentration used (50 ng/L). In fact, in subsequent works performed in our 324 
group we increased the amount of ILIS added to the samples obtaining a significant 325 
improvement in the results. 326 
3.1.2. Analysis of surface water samples 327 
A total of 57 river water samples (19 per campaign) were analysed by LC-MS/MS (QqQ) 328 
for 40 target pharmaceuticals. The compounds were selected based on their frequent 329 




studies (Botero-Coy et al., 2018; Hernández et al., 2015a, 2015b). The concentrations 331 
found in the samples analysed are included in Tables S8, S9 and S10, corresponding to 332 
the first (June 2018, summer), second (September 2018, autumn) and third (February 333 
2019, winter) campaigns. Table 1 shows the frequency of detection (% positive samples) 334 
of the pharmaceuticals investigated. As indicated in section 2.5, the cut-off value used for 335 
the compounds detected was half of their LCL. 336 
Thirty-five out of the 40 compounds evaluated in this study were measured at least once 337 
in the samples. The analgesic acetaminophen was the most frequently detected (65% of 338 
samples above the cut-off value 2. 5 ng/L). The antiepileptic gabapentin (42% above 2.5 339 
ng/L), the antidepressant venlafaxine (40% above 2.5 ng/L), the antihypertensive 340 
valsartan (39% above 2.5 ng/L), the antibiotic ciprofloxacin (33% above 25 ng/L) and the 341 
anti-inflammatory drug diclofenac (33% above 2.5 ng/L) were also frequently found. A 342 
notable amount of pharmaceuticals (66% of the compounds detected) exceeded, in at 343 
least one of the samples, the concentration level of 0.1 g/L (value set by European Union 344 
countries). The compounds with the highest percentage of exceedances were primidone, 345 
gabapentin, valsartan and diclofenac. Seven drugs (tramadol, azithromycin, ciprofloxacin, 346 
gabapentin, irbesartan, valsartan and phenazone) slightly surpassed 1 g/L, particularly 347 
in the sites 17 and 18, but never exceeded 2 g/L. Some of the pharmaceuticals detected 348 
in the Mijares River are currently included in the Watch List of substances for European-349 
wide monitoring in the field of water policy (European Commission, 2018), such as the 350 
antibiotics ciprofloxacin, clarithromycin, erythromycin and azithromycin. As an example, 351 
Figure S2 shows the positive findings of losartan (antihypertensive), diclofenac (NSAID) 352 
and erythromycin (antibiotic) in three surface water samples investigated. 353 
The spatial distribution along the Mijares River, expressed as the sum of the average 354 
concentration of the 3 campaigns of each individual pharmaceutical, is shown in Figure 355 
2. As expected, the upper section was the less contaminated (< 100 ng/L for total 356 
pharmaceuticals), even in the points near the fertilizer factory (site 2) and the fish farm 357 
(sites 3 and 4), which presented a similar pattern to the rest of upper sites demonstrating 358 
no relevant contribution of pharmaceutical residues into the Mijares River. 359 
As regards to the middle section, most of the sampling points showed mean 360 




11: Toga; 12: Sitjar reservoir; 12-13: Onda SWTP). It is worth noticing the sample collected 362 
downstream Montanejos WWTP (point 10), with a total concentration of 363 
pharmaceuticals above 5000 ng/L and high number of positives (up to 27 pharmaceuticals 364 
in the 1st campaign). On the contrary, the sampling site 11 (downstream WWTP Toga) did 365 
not appear to be very contaminated, which may be explained by the small size of this 366 
village with only 100 inhabitants. Moreover, in the sample collected downstream of the 367 
SWTP located in Onda (points 13 and 14) very few pharmaceuticals were found (< 100 368 
ng/L), indicating that no relevant pollution in terms of pharmaceuticals comes from this 369 
plant. This is in agreement with data reported on groundwater from that area, where 370 
pesticides were found as the most relevant contaminants due to the intensive agriculture 371 
in the surrounding area, focused on citrus crops (Pitarch et al., 2016).  372 
As expected, the lower section of the river was the most contaminated, especially in the 373 
area nearest to the estuary. The most polluted sites (total concentration >5000 ng/L) 374 
were located downstream of the two WWTPs, near Vila-real (point 17) and Almassora 375 
(point 18). Surface water collected in these two sampling sites presented the highest 376 
number of positives (between 20 and 30, depending on the campaign). The last sampling 377 
site, near the river mouth into the Mediterranean Sea (19, Gola Almassora), also 378 
presented a notable pharmaceuticals pollution, but with mean total concentrations 379 
below 5000 ng/L. 380 
3.2. Seasonal variation 381 
The total concentration for the different pharmaceutical families in each sampling 382 
campaign is shown in Figure 3. Antihypertensive, anti-inflammatory agents and 383 
antibiotics presented the highest concentrations. No clear trends were observed as a 384 
function of the sampling season, although a slight increase in concentrations of 385 
antihypertensives, antidepressants, antibiotics and analgesics seemed to occur in winter 386 
(3rd sampling). This fact is not surprising in the case of antibiotics due to the increase of 387 
their consumption to treat respiratory infections in colder periods (Letsinger et al. 2019).  388 
Due to the higher pollution observed in sampling sites 10, 17 and 18, specific data from 389 
these samples were evaluated to highlight possible seasonal trends. The antibiotics 390 
azithromycin, clarithromycin and trimethoprim were present at higher concentrations in 391 




concentrations in winter, at least in 2 out of the 3 sampling sites: the antibiotics 393 
clindamycin, erythromycin, sulfamethoxazole and metronidazole; the antihypertensives 394 
irbesartan, losartan and valsartan; the benzodiazepine alprazolam; the antiepileptic 395 
primidone; and the analgesic tramadol. The fact that pharmaceuticals presented higher 396 
concentrations in winter is in agreement with other river monitoring campaigns (Conley 397 
et al., 2008; Daneshvar et al., 2010; Lindholm-Lehto et al., 2016). Moreover, during cold 398 
periods, there is less degradation of the compounds in the WWTPs due to the low 399 
temperatures and irradiation, which result in higher analyte concentration levels in the 400 
effluent wastewater and, therefore, in the receiving surface water (Azzouz and 401 
Ballesteros, 2013; Golovko et al., 2014; Lindholm-Lehto et al., 2016). 402 
3.3 Screening of pharmaceuticals and metabolites 403 
A qualitative screening using UHPLC-QTOF MS was applied to samples collected in the 404 
second campaign to complement quantitative data and obtain information about other 405 
compounds that could be present in the samples. Table S11 shows the detection 406 
frequency of pharmaceuticals. In total, 41 pharmaceuticals were detected, and up to 35 407 
were confirmed with reference standards. Six more compounds were tentatively 408 
identified on the basis of the interpretation of accurate-mass data acquired, but could 409 
not be confirmed because the reference standard was not available at our laboratory. 410 
Compounds with the highest detection frequency were acetaminophen and venlafaxine, 411 
identified in 4 out of the 19 samples. Six pharmaceuticals (azithromycin, carbamazepine, 412 
diclofenac, irbesartan, lidocaine and sulfamethoxazole) were found in 3 samples (16%). 413 
As expected, the upper section (points 1-6) presented the lowest number of findings, 414 
illustrating the little anthropogenic influence on this area. Regarding sites located 415 
downstream of the SWTP in Onda (13 and 14), no analytes were found indicating that no 416 
relevant pharmaceutical pollution comes from this plant, which is in agreement with 417 
quantitative results obtained in the three campaigns. As expected, the highest number of 418 
findings corresponded to water samples collected WWTP downstream, especially near 419 
Vila-real (point 17) and Almassora (point 18). 420 
Figure 4 shows a summary of the results obtained in the screening, grouped by 421 
pharmaceutical families. Antihypertensives and non-steroidal anti-inflammatory drugs 422 




by antibiotics (12%). The remaining families were below 10%. Other compounds, mainly 424 
identified in points 17 and 18, were amisulpride (antipsychotic), cetirizine 425 
(antihistamine), dimetridazole (antiparasitic), iopromide (X-ray contrast agent), 426 
rimantadine (antiviral agent), each one with 2.2%, and lidocaine (anesthetic, 4.4%). Most 427 
of the compounds identified by HRMS screening have been often reported in surface 428 
water by the scientific literature (Gómez et al., 2010; Hernández et al., 2015b; Ibáñez et 429 
al., 2009; López et al., 2014; Masiá et al., 2013). 430 
From the 41 pharmaceuticals identified in the screening, 16 were already included in the 431 
target quantitative method applied in this work (marked with √ in Table 1). It must be 432 
taken into account that the quantitative UHPLC-MS/MS method offer much better 433 
sensitivity than the screening methodology, as it was optimized for a limited number of 434 
compounds and the TQS instrument has higher sensitivity than our QTOF instrument. It 435 
is therefore noteworthy that the detection frequency depends, not only on the 436 
concentration of the compound, but on the sensitivity of the method towards that 437 
particular compound. Hence, a lower detection frequency should not necessarily be 438 
associated to lower presence. The results from this screening will be useful to update the 439 
analytical methodology, by adding the compounds identified in the screening to the list 440 
of target analytes for quantitative UHPLC-MS/MS analysis. 441 
The excellent potential of UHPLC-HRMS also allowed to investigate pharmaceutical 442 
metabolites with the aim to generate useful data for future monitoring, including relevant 443 
metabolites detected in surface water. The screening of metabolites was focused on the 444 
most contaminated samples (i.e. those collected in sampling sites 10, 17, 18 and 19) to 445 
facilitate their detection and identification. Table 2 shows the nine metabolites 446 
(tentatively) identified in surface water. 6 out of 9 metabolites could be confirmed with 447 
reference standards. 448 
4-acetylaminoantipyrine (4-AAA) and 4-formylaminoantipyrine (4-FAA), metabolites of 449 
the antipyretic drug dipyrone (metamizole), were identified in the 4 samples analysed. 450 
Furthermore, 4-OH omeprazole sulphide, carbamazepine-10,11-epoxide and clopidogrel 451 
carboxylic acid were also found in 2 out of the 4 samples, while 4-aminoantipyrine (4-AA) 452 




These metabolites have also been found in surface water in previous studies performed 454 
by our group (Boix et al., 2016, 2014; Gracia-Lor et al., 2014).  455 
Three metabolites could only be tentatively identified as the reference standards were 456 
not available at our laboratory. The potential of QTOF MS for investigation of metabolites 457 
is illustrated in Figure S3, which shows the tentative identification of nordiazepam (N-458 
desmethyldiazepam) in a sample that also contained the parent compound diazepam (for 459 
more details, see S.M.) 460 
3.4. Ecological risk assessment 461 
The results of the ecological risk assessment performed with SSDs built with chronic 462 
NOECs show that the majority of the sampling sites are exposed to a low mixture toxic 463 
pressure (msPAFTotal below 5%; Figure 5). However the site 19 was considered to be 464 
moderately impacted, with msPAFs ranging between 5% and 25%; and sites 10, 17 and 465 
18 were severely impacted, with calculated msPAFTotal above 25%. Particularly, in sites 17 466 
and 18 (in all sampling campaigns), and in 10 (in summer), the percentage of affected 467 
aquatic species ranged between 65% and 82%, indicating a very high ecotoxicological risk 468 
(Figure 5). In all cases, toxicity was dominated by the analgesic/anti-inflammatory TC 469 
(msPAFTC 15-81%). Within this TC, toxicity was clearly dominated by phenazone, although 470 
diclofenac also had an important contribution (Tables S12-14). The second TC with the 471 
highest calculated toxicity were the bactericides (antibiotics), with a msPAFTC ranging 472 
between 5% and 12% in sampling sites 10 (all sampling campaigns), 17 (summer and 473 
winter) and 18 (autumn and winter). Within this TC, toxicity was dominated by 474 
azithromycin in autumn and winter (in sites 10, 17 and 18). In summer, the toxicity of this 475 
TC was dominated by norfloxacin, although other antibiotics such as ciprofloxacin and 476 
clarithromycin also contributed to the toxicity of the mixture. Regarding each of the 477 
monitored compounds in isolation, the highest ecological risks were established for 478 
phenazone >  azithromycin > diclofenac, with individual PAFs above 10% in at least one 479 
sampling site; and to a lower extent norfloxacin, ciprofloxacin and clarithromycin, with 480 
individual PAFs above 1% in at least one sampling site (Tables S12-S14). 481 
The method based on SSDs, and the calculated msPAFs, is a more ecological relevant 482 
approach when compared to other methods (e.g. Toxic Unit) to assess the risk of chemical 483 




many taxa as possible and accounts for their sensitivity differences on the basis of a 485 
statistical distribution. The capacity of the SSD approach to represent ecosystem effects 486 
has been evaluated on the basis of field monitoring studies and micro- and mesocosm 487 
experiments performed mainly with pesticides (e.g. Schäfer et al. 2013; Rico et al. 2018). 488 
Due to the absence of validation studies performed with pharmaceuticals, it is somewhat 489 
difficult to characterize the level of impact caused by each of the established risk 490 
categories. We expect that in the sites classified with severe risks (PAF or msPAFTotal above 491 
25%), the NOEC exceedances contributes to a loss of species that results in significant 492 
indirect ecological effects and in effects on important ecological functions. However, 493 
further investigations should be performed to quantify these effects and to validate the 494 
SSD method with pharmaceutical compounds.   495 
One of the major drawbacks of the SSD approach for its implementation in 496 
pharmaceutical risk assessment is the limited amount of experimental chronic toxicity 497 
data available. In this way, chronic SSDs often need to be based on extrapolated or read-498 
across toxicity data. For example, the µ of the chronic SSD for phenazone were based on 499 
the extrapolation of the µ for the acute one (2.5 µg/L), which was in turn constructed 500 
with a limited number of QSAR-based toxicity data (Posthuma et al. 2019; Table S7). 501 
Toxicity studies performed with other non-steroidal anti-inflammatory drugs, such as 502 
diclofenac, have shown cellular toxicity, genotoxicity, immunodepression, growth 503 
inhibition and estrogenic effects on fish at environmentally relevant concentrations 504 
(Hoeger et al., 2005; Hong et al., 2007; Xu et al., 2019). Therefore, experiments aimed at 505 
assessing the chronic toxicity of phenazone on fish are highly recommended. Regarding 506 
the other high priority compounds, the SSDs for azithromycin, ciprofloxacin and 507 
clarithromycin were based on a relatively large number of toxicity data, but relied on 508 
acute-to-chronic toxicity data extrapolations, while the SSD for norfloxacin was based on 509 
available chronic toxicity data (Table S7). Previous studies show that these compounds 510 
are highly toxic to aquatic microorganisms, including cyanobacteria and some diatoms 511 
(Guo et al., 2015). Therefore, their ecotoxicological risks may be associated to the 512 
alteration of the structure of microbial communities and primary producers, most likely 513 
those associated to hard substrates, downstream of areas with significant WWTP 514 




Furthermore, several studies show that ecosystem functions mediated by these 516 
microorganisms (e.g. nitrification, denitrification, anaerobic ammonium oxidation) can be 517 
affected by prolonged exposure to concentrations similar to those that have been found 518 
in this study  (Roose-Amsaleg and Laverman, 2016). 519 
Although a large number of pharmaceuticals have been monitored in this study, the 520 
results of the aquatic risk assessment show that only a very limited number of compounds 521 
has a potential contribution to the total toxicity of the sample. This is in line with other 522 
studies evaluating the potential ecotoxicological of pharmaceutical mixtures, which 523 
demonstrate that usually a reduced number of compounds (≤5) significantly contribute 524 
to the total toxicity of the sample ( Schäfer et al. 2013; Arenas-Sánchez et al., 2019). In 525 
our study, two TCs were the main responsible for the toxicity observed in the most 526 
polluted sites (i.e., analgesic/anti-inflammatory drugs and antibiotics). In principle, 527 
effects other than additive or antagonistic between these pharmaceutical groups are not 528 
expected on the impacted ecosystem, as they affect species in well separated trophic 529 
levels (i.e., cyanobacteria and fish). In addition, toxicity studies assessing the effects of 530 
non-steroidal anti-inflammatory drug mixtures on fish and other aquatic organisms 531 
(Cleuvers, 2004; Sehonova et al., 2017), or antibiotic mixtures on algae (González-Pleiter 532 
et al., 2013) generally demonstrate additivity, confirming that the concentration addition 533 
model used in this study for chemicals within the same TC is not expected to 534 
underestimate, neither overestimate, the calculated risks.  535 
3.5 Antibiotic resistance risks 536 
RQs exceeding the value of 1 were calculated in 3 out of the 19 evaluated sampling sites 537 
of the Mijares River (sites 10, 17 and 18). Resistance PNECs were exceeded by five 538 
antibiotics (see Figure 6), being ciprofloxacin the compound with the highest RQ (17.3), 539 
followed by azithromycin (6.5), norfloxacin (1.9), trimethoprim (1.5) and clarithromycin 540 
(1.3). In some samples, exceedance of resistance thresholds occurred for more than one 541 
antibiotic (e.g. ciprofloxacin and norfloxacin; azithromycin and clarithromycin). Overall 542 
the antibiotics with the highest resistance development risk belong to the 543 
fluoroquinolone and the macrolide classes, which are classified as antibiotics of critical 544 
importance for human health (WHO, 2019). This study shows that WWTPs discharges into 545 




to the enrichment of resistance genes in aquatic bacterial communities. However, the 547 
link between these indicators and the risks to the human population are not that 548 
straightforward. The assessment of the human transmission risks depends on the 549 
exposure levels (via bathing, irrigation, drinking), and require a complementary in-situ 550 
evaluation of fecal contamination, resistant bacteria, genes and mobile genetic elements 551 
(Huijbers et al., 2019), which is out of the scope of this study. At this stage, however, this 552 
study evidences that antibiotics in the EU Watch List (and others co-occurring with them) 553 
should be evaluated, not only regarding their potential ecotoxicological side-effects, but 554 
also regarding their contribution to antibiotic resistance development in the 555 
environment.  556 
 557 
 558 
4. CONCLUSIONS 559 
A comprehensive investigation has been made on the occurrence and risks of 560 
pharmaceuticals in the Mijares River (Eastern Spain). Up to 35 pharmaceuticals were 561 
quantified in the water samples analyzed. The impact of wastewater effluents was 562 
evidenced by a notable increase of pharmaceutical concentrations as well as in the 563 
number of compounds detected in the samples collected downstream of WWTP 564 
discharges. The effect of the WWTP was observed even for small populations located 565 
along the river. The compounds most frequently found were acetaminophen, 566 
gabapentin, venlafaxine, valsartan, ciprofloxacin and diclofenac. 567 
The complementary use of target quantitative methodology and qualitative wide-scope 568 
screening, allowed to have a more complete overview on the pharmaceuticals present in 569 
water. Accurate-mass data acquired by UHPLC-HRMS also allowed to investigate the 570 
presence of metabolites, leading to the identification of nine compounds, of which 4-571 
acetylaminoantipyrine (4-AAA), 4-formylaminoantipyrine (4-FAA), 4-OH omeprazole 572 
sulphide, carbamazepine-10,11-epoxide and clopidogrel carboxylic acid were the most 573 





A probabilistic risk assessment for aquatic organisms has been performed, indicating 576 
moderate-to-severe ecological risks in four sampling points downstream of WWTP 577 
discharges. The toxicity of the pharmaceutical mixture was dominated by analgesic/anti-578 
inflammatory drugs and antibiotics, and the compounds with the highest contribution to 579 
the toxicity were phenazone > azithromycin > diclofenac > norfloxacin, ciprofloxacin > 580 
clarithromycin. Out of these six compounds, only three are currently included in the EU 581 
Watch List. Out of the 13 antibiotic compounds evaluated in this study, 5 were found to 582 
exceed threshold concentrations for antibiotic resistance, particularly in the sampling 583 
sites downstream of WWTP discharges. Therefore, this study supports the advancement 584 
of water sanitation methods to minimize ecological and antibiotic resistance risks in the 585 
Mijares River.  586 
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Table 1. Target pharmaceuticals and results obtained by UHPLC-MS/MS (QqQ) quantitative analysis of water 925 
samples collected in the three campaigns. Percentages were calculated from a total number of 57 samples. 926 
Lowest calibration level (LCL), used as limit of quantification.  The value of LCL/2 was taken as the cut-off 927 




Positive samples > 
0.1 g/L (%) 
Maximum level 
found (g/L) 
LCL             
(ng/L) 
Analgesics Acetaminophen √ 65 2 0.20 5 
Tramadol √ 17 14 1.9 5 
Anthelmintic agents Levamisol 16 2 0.11 5 
Antibiotics Clindamycin 16 4 0.13 5 
Sulfadiazine  5 0 0.020 5 




Tetracycline  9 0 0.011 5 
Trimetroprim 12 7 0.72 5 
Azithromycin* √ 16 10 1.6 50 
Ciprofloxacin*a 33 5 1.1 50 
Clarithromycin* √ 14 12 0.33 5 
Erythromycin* 17 2 0.12 5 
Furaltadone 0 0 - 5 
Lincomycin 9 0 0.011 5 
Metronidazole 10 2 0.11 5 
Nalidixic acid 2 2 d 5 
Norfloxacina 25 5 0.94 50 
Oxolinic acid 19 0 d 5 
Roxithromycin 0 0 - 5 
Antidepressants Venlafaxine √ 40 14 0.80 5 
Antiepileptics Gabapentin √ 42 16 1.9 5 
Carbamazepine √  19 0 0.026 5 
Primidone 26 17 1.0 5 
Antihipertensives Enalapril 0 0 - 5 
Irbesartan √ 23 12 1.7 5 
Losartan √ 19 12 0.68 5 
Valsartan √ 39 16 1.6 5 
Antiulcer drugs Omeprazole sulfide-4-
hydroxy √ 19 7 0.15 
5 
Pantoprazole 14 0 0.013 5 
Benzodiazepines Alprazolam  19 0 0.020 5 
Lorazepam √ 16 0 0.094 10 
Beta-blocker agents Metoprolol 14 0 0.057 5 
Salbutamol 17 0 0.023 
5 
Hypolipidemic agents Atorvastatin  12 2 0.21 5 
Bezafibrateb  9 0 d 1000 
Gemfibrozilb 0 0 - 1000 
Nonsteroidal anti-
inflammatory 
Diclofenac √ 33 16 0.94 5 
Ketoprofenb √ 0 0 - 1000 
Naproxenb √ 14 0 d 1000 
Phenazone 21 14 2.0 10 
*Compounds included in the Watch List of the Commission Decision 2018/840 929 
√ Compounds also detected in the UHPLC-QTOF MS screeninga Results in positive samples should be taken as guidance 930 
values since accurate quantification could not be made 931 
b Compounds with LCL higher than 0.1 g/L, so positive samples > 0.1 g/L is not applicable 932 
d, detected: concentration below LCL and at least one q/Q ratio was accomplished 933 
 934 
Table 2. Metabolites and/or transformation products of pharmaceuticals identified in surface water samples 935 
by UHPLC-QTOF MS. 936 
Compounds 
Samples 
10b 17b 18b 19b 
4-AA (4-Aminoantipyrine)  ̶ ̶ ̶ 




4-FAA (4-Formylaminoantipyrine)     
Carbamazepine-10,11-epoxide ̶   ̶ 
Clopidogrel carboxylic acid ̶   ̶ 
O-Desmethyl venlafaxine  ̶ t t ̶ 
4-OH Omeprazole sulphide ̶   ̶ 
Losartan carboxylic acid  ̶ t t ̶ 
Nordiazepam (N-desmethyldiazepam) ̶ t t ̶ 
 ✓: confirmed with reference standard, ((de)protonated molecule and at least one fragment ion were  937 
     observed at the expected retention time). 938 
  t: tentative identification ((de)protonated molecule was observed and at least one ion fragment was justified). 939 

















Figure 1. Location of the sampling sites and WWTPs along the Mijares River 954 
 955 
Figure 2. Spatial distribution as total average concentration of pharmaceuticals in Mijares River. In the left 956 
side, the number of pharmaceuticals found in each sampling site per campaign is shown (1st: June 2018; 957 





Figure 3. Total pharmaceutical concentrations (µg/L) (grouped by families) in the Mijares River in every 960 
sampling campaign (1st campaign: June 2018; 2nd campaign: September 2018; 3rd campaign: February 961 
2019).  NSAIDs: Nonsteroidal anti-inflammatory drugs 962 
 963 
 964 
Figure 4. Percentages of the different families of pharmaceuticals identified 965 
in the Mijares River by UHPLC-QTOF MS screening. NSAIDs: Nonsteroidal 966 
anti-inflammatory drugs. The “Others” category includes the following 967 
types of pharmaceuticals: anesthetics, antihistamines, antiparasitics, 968 

















Figure 5. Calculated total chronic toxicity (msPAFTotal) for each sample and relative 974 
contribution of each specific therapeutic class to the total toxic pressure. The orange line 975 
indicates an msPAFTotal of 5%, and the red line an msPAFTotal of 25%. a, b, c refer to the 976 
samples taken in the first, second and third sampling campaigns, respectively (1st campaign: 977 
June 2018; 2nd campaign: September 2018; 3rd campaign: February 2019) 978 
 979 
 980 
Figure 6. Calculated RQs for the antibiotics that are expected to result in antibiotic 981 
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one are represented. a, b, c refer to the samples taken in the first, second and third sampling 983 
campaigns, respectively (1st campaign: June 2018; 2nd campaign: September 2018; 3rd 984 
campaign: February 2019 985 
